CO5611146A2 - 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas, su produccion y su uso en medicamentos - Google Patents

3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas, su produccion y su uso en medicamentos

Info

Publication number
CO5611146A2
CO5611146A2 CO04083779A CO04083779A CO5611146A2 CO 5611146 A2 CO5611146 A2 CO 5611146A2 CO 04083779 A CO04083779 A CO 04083779A CO 04083779 A CO04083779 A CO 04083779A CO 5611146 A2 CO5611146 A2 CO 5611146A2
Authority
CO
Colombia
Prior art keywords
group
substituted
alkyloxy
alkyl
alkyl group
Prior art date
Application number
CO04083779A
Other languages
English (en)
Spanish (es)
Inventor
Karl Schoenafinge
Stefan Petry
Guenter Mueller
Armin Bauer
Hubert Otto Heuer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of CO5611146A2 publication Critical patent/CO5611146A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
CO04083779A 2002-02-28 2004-08-26 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas, su produccion y su uso en medicamentos CO5611146A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208987A DE10208987A1 (de) 2002-02-28 2002-02-28 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen

Publications (1)

Publication Number Publication Date
CO5611146A2 true CO5611146A2 (es) 2006-02-28

Family

ID=27740558

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04083779A CO5611146A2 (es) 2002-02-28 2004-08-26 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas, su produccion y su uso en medicamentos

Country Status (22)

Country Link
EP (1) EP1480960B1 (cg-RX-API-DMAC10.html)
JP (1) JP4486363B2 (cg-RX-API-DMAC10.html)
KR (1) KR20040095240A (cg-RX-API-DMAC10.html)
CN (1) CN1639137A (cg-RX-API-DMAC10.html)
AR (1) AR038701A1 (cg-RX-API-DMAC10.html)
AT (1) ATE557012T1 (cg-RX-API-DMAC10.html)
AU (1) AU2003226977A1 (cg-RX-API-DMAC10.html)
BR (1) BR0307921A (cg-RX-API-DMAC10.html)
CA (1) CA2477031A1 (cg-RX-API-DMAC10.html)
CO (1) CO5611146A2 (cg-RX-API-DMAC10.html)
DE (1) DE10208987A1 (cg-RX-API-DMAC10.html)
HR (1) HRP20040782A2 (cg-RX-API-DMAC10.html)
HU (1) HUP0402671A3 (cg-RX-API-DMAC10.html)
IL (1) IL163683A0 (cg-RX-API-DMAC10.html)
MA (1) MA27172A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA04007960A (cg-RX-API-DMAC10.html)
NO (1) NO20044090L (cg-RX-API-DMAC10.html)
PE (1) PE20030928A1 (cg-RX-API-DMAC10.html)
PL (1) PL370423A1 (cg-RX-API-DMAC10.html)
RU (1) RU2004128933A (cg-RX-API-DMAC10.html)
TW (1) TW200400951A (cg-RX-API-DMAC10.html)
WO (1) WO2003072555A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
RU2007119315A (ru) 2004-10-25 2008-11-27 Зольвай Фармасьютиклз Гмбх (De) Фармацевтические композиции, содержащие антагонисты каннабиноидного рецептора св1 и открыватели калиевых каналов, предназначенные для лечения сахарного диабета типа i, ожирения и связанных с ними состояний
BRPI0821482A2 (pt) * 2007-12-27 2015-07-14 Bial Portela & Ca Sa 3-n-fenil-1,3,4-oxadiazolona 5-o-substituída, seu uso, sua composição e seu processo de preparação
AR074978A1 (es) 2008-12-23 2011-03-02 Bial Portela & Ca Sa 3-n-aril-1,3,4-oxadiazolonas 5-o-sustituidas para uso en el tratamiento del dolor y procedimiento de obtencion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
WO2001066531A1 (de) * 2000-03-07 2001-09-13 Aventis Pharma Deutschland Gmbh Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one (und) ihre verwendung zur hemmung der hormonsensitiven lipase

Also Published As

Publication number Publication date
EP1480960A1 (de) 2004-12-01
AR038701A1 (es) 2005-01-26
CN1639137A (zh) 2005-07-13
NO20044090L (no) 2004-11-04
PE20030928A1 (es) 2003-12-17
BR0307921A (pt) 2004-12-21
HRP20040782A2 (en) 2005-02-28
HUP0402671A3 (en) 2006-07-28
TW200400951A (en) 2004-01-16
JP2005519085A (ja) 2005-06-30
JP4486363B2 (ja) 2010-06-23
DE10208987A1 (de) 2003-09-11
IL163683A0 (en) 2005-12-18
ATE557012T1 (de) 2012-05-15
AU2003226977A1 (en) 2003-09-09
MXPA04007960A (es) 2004-11-26
CA2477031A1 (en) 2003-09-04
WO2003072555A1 (de) 2003-09-04
EP1480960B1 (de) 2012-05-09
PL370423A1 (en) 2005-05-30
MA27172A1 (fr) 2005-01-03
RU2004128933A (ru) 2005-04-20
KR20040095240A (ko) 2004-11-12
HUP0402671A2 (hu) 2005-04-28

Similar Documents

Publication Publication Date Title
AR117916A1 (es) Compuesto heterocíclico y su uso
CO6260062A2 (es) (carboxilalquilenfenil)feniloxamidas metodo para su produccion y uso de las mismas como medicamentos
ECSP088550A (es) Nuevos compuestos que son inhibidores de erk
CO5590956A2 (es) Derivados sustituidos de fenilo
AR049784A1 (es) Derivados sustituidos de morfolina y tiomorfolina
NI200600322A (es) Inhibidores de cetp
ECSP077274A (es) Derivados de n-2 adamantanil-2-fenoxi-acetamida como inhibidores de deshidrogenasa 11-beta hidroxiesteroide
AR034282A1 (es) Derivados de difenilazetidinona, medicamentos que contienen estos compuestos, procedimiento para su preparacion, y su utilizacion para la preparacion de medicamentos
AR042936A1 (es) Derivados de urea ciclica, su preparacion y su utilizacion farmaceutica como inhibidores de quinasas
PE20040688A1 (es) Inhibidores de quinasas
CO6210721A2 (es) Acilaminopirazoles como inhibidores de fgfr
AR046938A1 (es) Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
AR039868A1 (es) Inhibidores selectivos de la enzima kalikreina plasmatica
DK1578943T3 (da) Nye variant-Hypocrea jecorina-CBH1-cellulaser
AR053994A1 (es) Sulfonilpirrolidinas sustituidas procedimiento para su preparacion y su uso como medicamentos
ES2436020T3 (es) Derivados de sulfonamida sustituidos
NO20100728L (no) Fremgangsmate for fremstilling av N-monosubstituerte beta-aminoalkoholer
CO5251431A1 (es) Derivados quimicos y su aplicacion como agente antitelomerasa
AR054195A1 (es) Derivados de indol como inhibidores de la fosfolipasa a2 citosolica y composicion farmaceutica que los contiene
CO5700820A2 (es) Derivados de dioxan-2-alquilcarbamatos, su preparacion y su aplicacion en terapeutica
AR103742A1 (es) Derivados de trifluorometilpropanamida
CO5540388A2 (es) Nuevas arisulfonamidas como agentes antivirales
ES2177275T3 (es) Derivados de oxadiazolina y su uso como insecticidas.
ECSP078009A (es) Derivados del 4,5-diarilpirrol, su preparación y su aplicación en terapéutica
AR055666A1 (es) Inhibidores inntr

Legal Events

Date Code Title Description
FA Application withdrawn